Gongwin Biopharm Holdings Co., Ltd. (TPEX:6617)

Gongwin Biopharm Holdings Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Feb 20, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	14,749	20,911	36,132	31,104	26,551	8,244
Market Cap Growth	-30.79%	-42.13%	16.16%	17.15%	222.07%	20.08%
Enterprise Value	12,574	20,036	35,498	30,383	26,037	7,660
Last Close Price	116.50	184.50	319.50	279.64	240.11	77.17
PS Ratio	471.66	1105.50	31611.24	27212.59	31874.31	33242.01
PB Ratio	4.64	15.94	26.31	31.50	23.74	11.83
P/TBV Ratio	4.70	15.90	25.96	32.04	24.29	12.39
EV/Sales Ratio	388.44	1059.26	31056.74	26581.68	31256.89	30885.30
Debt / Equity Ratio	0.04	0.06	0.10	0.12	0.03	0.03
Asset Turnover	0.01	0.01	0.00	0.00	0.00	0.00
Inventory Turnover	1.34	1.27	-	-	-	-
Quick Ratio	14.27	7.58	5.80	5.34	18.67	13.41
Current Ratio	15.28	8.86	6.99	5.95	19.05	13.61
Return on Equity (ROE)	-4.40%	-7.54%	-24.75%	-12.34%	-10.94%	-15.61%
Return on Assets (ROA)	-3.76%	-5.31%	-11.66%	-6.36%	-7.41%	-9.43%
Return on Capital (ROIC)	-3.99%	-5.74%	-12.45%	-6.69%	-7.83%	-10.06%
Earnings Yield	-0.70%	-0.48%	-0.81%	-0.39%	-0.35%	-1.33%
FCF Yield	-1.91%	-0.53%	-0.66%	-0.70%	-0.44%	-1.30%
Buyback Yield / Dilution	-3.70%	-1.92%	-1.44%	-4.87%	-1.37%	-2.13%
Total Shareholder Return	-3.70%	-1.92%	-1.44%	-4.87%	-1.37%	-2.13%

Source: S&P Capital IQ. Standard template. Financial Sources.